Relationship between Drug Vitamin D Intake and Pre-menstrual Syndrome among Women of Reproductive Age
Premenstrual Syndrome (PMS) is a common problem among women in reproductive age, typically affecting those between the ages of 15 years-49 years, and often limiting their daily activities. It is characterized by somatic and psychological symptoms that significantly appear during the luteal phase of the menstrual cycle, usually 7 days to 14 days before menstruation begins. These signs cause substantial impairment and decrease functional capacity. Vitamin D therapy is a safe, effective, and affordable option to prevent and overcome this syndrome. Therefore, this research aims to analyze the relationship between vitamin D intake and Premenstrual Syndrome, as well as the role of subject characteristics such as age and menarche age in relation to the complication. Using a cross-sectional and descriptive-analytical approach, a sample of 81 participants was selected through the Consecutive Non-random Sampling technique. The shortened Premenstrual Symptoms Assessment Form (SPAF) was used to assess PMS, and the Semi-quantitative Food Frequency Questionnaire (SQFFQ) was used to evaluate vitamin D intake. The results, obtained through Chi-square and Fisher’s exact test analysis method, showed a significant relationship between vitamin D intake and PMS (p=0.00; p<0.05). Additionally, a relationship was identified between age and PMS (p=0.045; p<0.05), but no correlation was observed between menarche age and the syndrome (p=0.103; p>0.05). Therefore, it is suggested that increasing vitamin D intake through dietary means may reduce the incidence.